Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two cryoablation techniques for treating atrial fibrillation

Official title: Wide-Antral Pulmonary Vein Isolation in Patients Undergoing Atrial Fibrillation Ablation with a Single-shot Technique: the WIDER-PVI Trial

Run by Hospital Universitario 12 de Octubre · NCT06698159 · Data updated 2026-11-12

This study is testing whether a larger cryoablation technique can help people with atrial fibrillation have fewer heart rhythm problems after treatment compared to a smaller technique.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment440 (estimated)
SponsorHospital Universitario 12 de Octubre
Academic / other
Locations17 sites (Pozzilli, Isernia and 16 other locations)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedMay 1, 2026
Study endsJune 30, 2027
Registry record updatedNovember 20, 2024
Trial IDNCT06698159 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with a recent diagnosis of paroxysmal or persistent atrial fibrillation who require pulmonary vein isolation.

Probably not a fit

Patients with severe left atrial dilatation, previous ablation procedures, or significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The WIDER-PVI study is a multicenter randomized clinical trial designed to compare the efficacy of two cryoablation techniques for pulmonary vein isolation in patients with paroxysmal or persistent atrial fibrillation. Participants will undergo either antral isolation using a 28 mm cryoballoon or extended antral isolation using a 31 mm cryoballoon. The primary objective is to determine if the extended antral isolation technique results in lower recurrence rates of atrial tachyarrhythmias at one year follow-up. This study aims to provide insights into the effectiveness of newer, larger cryoablation devices in improving patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to more effective treatment options for patients with atrial fibrillation, potentially reducing the recurrence of arrhythmias.

How similar studies have gone: Previous studies have shown promising results with cryoablation techniques, but this specific comparison of antral versus extended antral isolation is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 18 years old.
* Previous diagnosis of paroxysmal or persistent atrial fibrillation less than 2 years after diagnosis.
* Clinical indication to undergo a pulmonary vein isolation procedure using balloon cryoablation.

Exclusion Criteria:

* Severe left atrial dilatation (indexed volume \>48 ml/m2 or area \>40 cm2 or indexed diameter \>3.0 cm/m2).
* Previous endocardial or surgical ablation of atrial fibrillation.
* Severe frailty (Clinical Frailty Scale score 7 or higher) or life expectancy less than 1 year.
* Inability to understand or give informed consent.
* Performance of other left atrial ablations in addition to pulmonary veins.
* Need to use another catheter in addition to the cryoablation catheter to complete pulmonary vein isolation.
* Contraindication to anticoagulation or intolerance to heparin.
* Presence of intra-atrial thrombus.
* Reversible cause of atrial fibrillation.
* Severe mitral or aortic valve disease.
* Congenital heart disease.
* Pregnancy or the prospect of pregnancy in the next 12 months.

Where it's running

  • Hospital Universitario 12 de Octubre
    Madrid, Spain
    Recruiting
  • IRCCS Neuromed Mediterranean Neurological Institute
    Pozzilli, Isernia, Italy
    Not yet recruiting
  • Casa di cura Villa dei Fiori
    Acerra, Napoli, Italy
    Not yet recruiting
  • Poliambulanza Institute Hospital Foundation
    Brescia, Italy
    Not yet recruiting
  • Ospedale Santa Maria Goretti
    Latina, Italy
    Not yet recruiting
  • Clinica San Michele
    Maddaloni, Italy
    Not yet recruiting
Show 11 more locations
  • Fondazione IRCCS San Gerardo dei Tintori
    Monza, Italy
    Not yet recruiting
  • Pellegrini Hospital
    Naples, Italy
    Not yet recruiting
  • Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova
    Padova, Italy
    Not yet recruiting
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University "Cattolica del Sacro Cuore"
    Rome, Italy
    Not yet recruiting
  • S. Pietro Fatebenefratelli Hospital
    Rome, Italy
    Not yet recruiting
  • HU Basurto
    Bilbao, Spain
    Not yet recruiting
  • HU Virgen de las Nieves
    Granada, Spain
    Not yet recruiting
  • HU Juan Ramón Jiménez
    Huelva, Spain
    Not yet recruiting
  • HU Ramón y Cajal
    Madrid, Spain
    Not yet recruiting
  • HU Virgen de la Victoria
    Málaga, Spain
    Not yet recruiting
  • HU Virgen Macarena
    Seville, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.